[Treating juvenile nephrotic syndrome with levamisol: regarding a marketing suspension]

Farm Hosp. 2010 May-Jun;34(3):148-9. doi: 10.1016/j.farma.2009.10.003. Epub 2010 Jan 29.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Child, Preschool
  • Cyclophosphamide / adverse effects
  • Cyclophosphamide / therapeutic use
  • Drug Recalls*
  • Female
  • Humans
  • Hydrochlorothiazide / therapeutic use
  • Levamisole / supply & distribution*
  • Levamisole / therapeutic use*
  • Nephrotic Syndrome / drug therapy*
  • Off-Label Use
  • Prednisone / therapeutic use
  • Recurrence
  • Remission Induction

Substances

  • Hydrochlorothiazide
  • Levamisole
  • Cyclophosphamide
  • Prednisone